GlassScriptPhysician profile
William Philip Arthur
NPI 1467803759
$3,853.90
in general payments reported to CMS, 2019-2025
26 companies · $80.12 in 2025
The $80.12 reported for 2025 was less than what a typical Sports Medicine (Podiatrist) provider received nationally (typical 2025 total: $307).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $821 · 2020: $215 · 2021: $581 · 2022: $1,095 · 2023: $304 · 2024: $757 · 2025: $80.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,141.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $821.00 | 2019 | |
| Boston Scientific Corporation | $523.20 | 2021-2024 | |
| Smith+Nephew, INC. | $511.03 | 2021-2025 | Regranex, Grafix, Renasys |
| Nevro Corp. | $466.86 | 2022-2024 | Senza |
| Organogenesis INC. | $391.99 | 2020-2024 | |
| Medtronic, INC. | $260.05 | 2022-2024 | Intellis Adaptivestim |
| In2bones USA, LLC | $114.69 | 2020 | |
| Abbvie INC. | $112.00 | 2023-2024 | Dalvance |
| Treace Medical Concepts, INC. | $77.30 | 2022-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $76.11 | 2020-2021 | |
| Horizon Therapeutics Plc | $73.86 | 2021-2023 | Krystexxa |
| Depuy Synthes Sales INC. | $71.82 | 2020-2024 | N/A |
| Grt US Holding, INC. | $61.34 | 2021 | |
| Averitas Pharma INC. | $52.33 | 2023-2024 | Qutenza |
| Paratek Pharmaceuticals, INC. | $36.94 | 2022-2023 | Nuzyra |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $33.95 | 2024 | Biobrace 23mm |
| Anika Therapeutics, INC. | $32.10 | 2021 | |
| Nabriva Therapeutics, Plc | $31.79 | 2021-2022 | |
| Tactile Systems Technology INC | $17.00 | 2024 | Entre Plus, Flexitouch Plus |
| Acera Surgical, INC. | $15.37 | 2022 | |
| Paragon 28, INC. | $14.87 | 2025 | Grappler |
| Amgen INC. | $13.53 | 2025 | Krystexxa |
| Kowa Pharmaceuticals America, INC. | $12.87 | 2022 | |
| Triad Life Sciences INC. | $11.79 | 2022 | |
| Alfasigma USA, INC. | $11.11 | 2021 | |
| Dynasplint Systems INC. | $9.00 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Arthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.